Role of n-3 fatty acids in muscle loss and myosteatosis
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Image-based methods such as computed tomography for assessing body composition enables quantification of muscle mass and muscle density and reveals that low muscle mass and myosteatosis (fat infiltration into muscle) are common in people with cancer. Myosteatosis and low muscle mass have emerged as independent risk factors for mortality in cancer; however, the characteristics and pathogenesis of these features have not been resolved. Muscle depletion is associated with low plasma eicosapentaenoic (20:5n-3) and docosahexaenoic (22:6n-3) in cancer and supplementation with n-3 fatty acids has been shown to ameliorate muscle loss and myosteatosis in clinical studies, suggesting a relationship between n-3 fatty acids and muscle health. Since the mechanisms by which n-3 fatty acids alter body composition in cancer remain unknown, related literature from other conditions associated with myosteatosis, such as insulin resistance and obesity is considered. In these noncancer conditions, it has been reported that n-3 fatty acids act by increasing insulin sensitivity, reducing inflammatory mediators, and altering adipokine profiles and transcription factors; therefore, the plausibility of these mechanisms of action in the neoplastic state are considered. The aim of this review is to summarize what is known about the effects of n-3 fatty acids with regards to muscle condition and to discuss potential mechanisms for effects of n-3 fatty acids on muscle health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prado, C. M., Lieffers, J. R., McCargar, L. J., Reiman, T., Sawyer, M. B., Martin, L., & Baracos, V. E. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70153-0 · Cited by 3,238
Janssen, I., Heymsfield, S. B., & Ross, R. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50216.x · Cited by 3,139
n−3 Polyunsaturated fatty acids, inflammation, and inflammatory diseases
Calder, P. C. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.6.1505s · Cited by 2,525 · cited 1×
“n-3 fatty acids reduce inflammation Supplementation with long-chain n-3 fatty acids results in antiinflammatory effects in both healthy populations and in models of chronic inflammatory conditions, and has been studied extensively in recent years (Browning 2003; Calder 2006; Robinson et al. 2007; Robinson and Mazurak…”
BackgroundMourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224 · cited 1×
“The attenuation ranges of muscle (45–50 HU) and total adipose tissue (–190 to –30 HU) have been defined (Heymsfield et al. 1997; Goodpaster et al. 2000; Roubenoff 2000; Janssen et al. 2002; Mourtzakis et al. 2008).”
BackgroundLeptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Shen, W., Punyanitya, M., Wang, Z., Gallagher, D., St.-Onge, M.-P., Albu, J., Heymsfield, S. B., & Heshka, S. (2004) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00744.2004 · Cited by 1,692 · cited 1×
“High resolution image-based techniques such as CT and MRI exhibit specificity and precision that have been extensively validated and applied in body composition research (Heymsfield et al. 1997; Mitsiopoulos et al. 1998; Shen et al. 2004).”
Mitsiopoulos, N., Baumgartner, R. N., Heymsfield, S. B., Lyons, W., Gallagher, D., & Ross, R. (1998) · Journal of Applied Physiology · doi:10.1152/jappl.1998.85.1.115 · Cited by 1,522 · cited 1×
“High resolution image-based techniques such as CT and MRI exhibit specificity and precision that have been extensively validated and applied in body composition research (Heymsfield et al. 1997; Mitsiopoulos et al. 1998; Shen et al. 2004).”
Goodpaster, B. H., Kelley, D. E., Thaete, F. L., He, J., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.104 · Cited by 947
Measurement of skeletal muscle radiation attenuation and basis of its biological variation
Aubrey, J., Esfandiari, N., Baracos, V. E., Buteau, F. A., Frenette, J., Putman, C. T., & Mazurak, V. C. (2014) · Acta Physiologica · doi:10.1111/apha.12224 · Cited by 720
Self-citationSmith, G. I., Atherton, P., Reeds, D. N., Mohammed, B. S., Rankin, D., Rennie, M. J., & Mittendorfer, B. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.005611 · Cited by 665 · cited 5×
“The requirement of EPA and DHA for muscle integrity has not been directly studied; however, evidence from studies by our group and others’ suggest improvement in muscle health occurs when a supply of EPA and DHA is maintained (Read et al. 2007; Castillero et al. 2009; Murphy et al. 2010a, 2011a; Hiller et al. 2011; Pe…”
BackgroundInfluential
Cited by
Cespedes Feliciano, E. M., Kroenke, C. H., Meyerhardt, J. A., Prado, C. M., Bradshaw, P. T., Kwan, M. L., Xiao, J., Alexeeff, S., Corley, D., Weltzien, E., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2319 · Cited by 427
Malietzis, G., Johns, N., Al-Hassi, H. O., Knight, S. C., Kennedy, R. H., Fearon, K. C. H., Aziz, O., & Jenkins, J. T. (2016) · Annals of Surgery · doi:10.1097/sla.0000000000001113 · Cited by 218
“Recent studies have considered the use of (n-3) fatty acids as beneficial in improving the attenuation of lean tissue.(36,37)”
BackgroundVignaud, J., Loiseau, C., Hérault, J., Mayer, C., Côme, M., Martin, I., & Ulmann, L. (2023) · Antioxidants · doi:10.3390/antiox12051050 · Cited by 72
“Although still elusive, the anabolic role ofω3-PUFAs on skeletal muscles is thought to be due to a reduction in proinflammatory cytokines and myosteatosis, an improvement in insulin sensitivity [166], MPS stimulation via the mTOR-p70S6K signaling pathway [167] and a decrease in mitochondrial ROS emission [168].”
BackgroundBounihi, A., Bitam, A., Bouazza, A., Yargui, L., & Koceir, E. A. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2016.1226369 · Cited by 50
“, obesity), accounts for adipocyte differentiation, and increases lipolysis and b-oxidation (Yeaman 2004; Ewaschuk et al. 2014), on one side, and high secretion of pro-inflammatory cytokines in the other (e.”
BackgroundPotential role of omega-3 fatty acids on the myogenic program of satellite cells
Bhullar, A. S., Putman, C. T., & Mazurak, V. C. (2016) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s27481 · Cited by 26
Self-citation
Metadata
- Authors
- Ewaschuk, J. B., Almasud, A., & Mazurak, V. C.
- Venue
- Applied Physiology, Nutrition, and Metabolism
- Publisher
- Canadian Science Publishing
- Published
- 2014-06
- Volume
- 39
- Issue
- 6
- Pages
- 654-662
- ISSN
- 1715-5312 (ISSN-L)
- 1715-5320
- OpenAlex
- W1855151202
- Cited by
- 54
- References
- 23
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Role of n-3 fatty acids in muscle loss and myosteatosis. https://app.cochat.ai/papers/10.1139/apnm-2013-0423
- The paper
- Ewaschuk, J. B., Almasud, A., & Mazurak, V. C. (2014). Role of n-3 fatty acids in muscle loss and myosteatosis. Applied Physiology, Nutrition, and Metabolism. https://doi.org/10.1139/apnm-2013-0423
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.